Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The history and evolution of HLA typing external proficiency testing schemes in UK NEQAS for H&I.

Frontiers in genetics·2023
Same author

Dental procedures in children with or without intellectual disability and autism spectrum disorder in a hospital setting.

Australian dental journal·2022
Same author

Osteosarcoma new trends in diagnosis and treatment.

Orthopedics·2014
Same author

Decay of Salmonella enterica, Escherichia coli and bacteriophage MS2 on the phyllosphere and stored grains of wheat (Triticum aestivum).

Letters in applied microbiology·2013
Same author

Long-term survival in high-grade soft-tissue sarcoma - prognostic factors in synovial sarcoma.

International journal of oncology·2011
Same author

Activated factor XII type A predicts long-term mortality in patients admitted with chest pain.

Journal of thrombosis and haemostasis : JTH·2008
Same journal

Short communication: Excretory-secretory antigens allow effective IgG detection in experimental Strongyloides hyperinfection under immunosuppression.

Journal of helminthology·2026
Same journal

Gastric nematode co-infections and redescription of <i>Neoterranova serrata</i> in <i>Arapaima gigas</i> from Central Amazon.

Journal of helminthology·2026
Same journal

<i>Ollulanus tricuspis</i> in Turkish cats: first clinical case and molecular confirmation.

Journal of helminthology·2026
Same journal

<i>In vitro</i> anthelmintic activity and mode of action of <i>Pleurotus djamor</i> basidiomes and mycelium extracts and fractions against <i>Haemonchus contortus</i> eggs.

Journal of helminthology·2026
Same journal

Anthelmintic resistance of gastrointestinal nematodes in cattle herds in mid-mountain central France.

Journal of helminthology·2026
Same journal

A new species of the genus <i>Monoecocestus</i> (Cestoda: Anoplocephalidae) from <i>Lagidium viscacia</i> (Rodentia: Chinchillidae) from the high-altitudes of Peru.

Journal of helminthology·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Worm therapy: for or against?

D Pritchard1

  • 1Immune Modulation Research Group, School of Pharmacy, University of Nottingham, UK. david.pritchard@nottingham.ac.uk

Journal of Helminthology
|July 7, 2011
PubMed
Summary
This summary is machine-generated.

This review examines the evidence for worm therapy, questioning if parasitic worms are sufficiently proven as investigational medicinal products for widespread use.

More Related Videos

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
06:32

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on: July 12, 2024

Related Experiment Videos

Last Updated: May 31, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
06:32

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on: July 12, 2024

Area of Science:

  • Medical Science
  • Parasitology
  • Drug Development

Background:

  • Worm therapy, also known as helminthic therapy, involves the use of parasitic worms for medical treatment.
  • There is a growing interest in exploring novel therapeutic agents, including biological treatments.

Purpose of the Study:

  • To review the existing evidence supporting the efficacy and safety of worm therapy.
  • To evaluate whether current data justifies the classification of parasitic worms as investigational medicinal products.

Main Methods:

  • Systematic literature review of studies on helminthic therapy.
  • Analysis of clinical trial data and case reports.
  • Assessment of the regulatory landscape for biological therapeutics.

Main Results:

  • The evidence base for worm therapy varies significantly across different conditions.
  • Some studies show promising results, while others lack robust data or have methodological limitations.
  • Regulatory pathways for parasitic worms as medicinal products are not well-established.

Conclusions:

  • The current evidence for worm therapy is not uniformly sufficient to support its broad use as investigational medicinal products.
  • Further high-quality research is needed to establish the safety and efficacy of specific helminth species for defined medical applications.
  • Consideration of regulatory frameworks is essential for the advancement of helminthic therapies.